Position history for ARK Investment Management LLC's holdings in CRISPR THERAPEUTICS AG
ARK Investment Management LLC holds 10.5M shares of CRSP (CRISPR THERAPEUTICS AG), worth $551.8M as of 2025-Q4. The position was increased (++7.5% shares). CRSP represents 3.7% of ARK Investment Management LLC's portfolio.
Current Value
$551.8M
Current Shares
10.5M
Total Value Change
+$131.7M
Total Shares Change
+2.7M
Other major holders of CRSP: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC, CAPITAL FUND MANAGEMENT S.A.
Increased |
| 10.5M |
+7.5% |
| $551.8M |
| 3.7% |
| $53.19 |
62 |
| 2025-Q3 | Decreased | 9.8M | -3.9% | $634.3M | 3.8% | $63.77 | 0 |
| 2025-Q2 | Increased | 10.2M | +0.2% | $495.3M | 3.6% | $47.49 | 57 |
| 2025-Q1 | Increased | 10.2M | +13.3% | $345.9M | 3.5% | $36.99 | 64 |
| 2024-Q4 | Increased | 9M | +19.7% | $353.2M | 2.9% | $38.65 | 63 |
| 2024-Q3 | Decreased | 7.5M | -3.6% | $352.3M | 3.2% | $47.32 | 0 |
| 2024-Q2 | Decreased | 7.8M | -4.6% | $420.1M | 3.7% | $54.01 | 0 |